1-4 of 4
Arinobu Tojo, M.D., Ph.D.
Close
Sort by
Journal Articles

RNAi-Mediated Silencing of p190Bcr-Abl Inactivates Stat5 and Cooperates with Imatinib Mesylate and 17-Allylamino-17-Demetoxygeldanamycin in Selective Killing of p190Bcr-Abl-Expressing Leukemia Cells.

Muneyoshi Futami, MD, Toshiyuki Hatano, Yasushi Soda, M.D., Ph.D., Seiichiro Kobayashi, M.D., Ph.D., Makoto Miyagishi, Ph.D., Arinobu Tojo, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2783.
https://doi.org/10.1182/blood.V110.11.2783.2783
Published: 2007
Journal Articles

Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Hui-Jen Tsai, MD, Seiichiro Kobayashi, M.D., Ph.D., Kiyoko Itoh, Ph.D., Takaomi Ishida, Ph.D., Kazuo Umezawa, Ph.D., Arinobu Tojo, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 723.
https://doi.org/10.1182/blood.V110.11.723.723
Published: 2007
Journal Articles

ShRNA Targeting p190BCR-ABL Successfully Eliminates Ph-ALL Cells with or without ABL Kinase Domain Mutation.

Muneyoshi Futami, MD, Toshiyuki Hatano, Yasushi Soda, M.D., Ph.D., Seiichiro Kobayashi, M.D., Ph.D., Makoto Miyagishi, Ph.D., Arinobu Tojo, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1838.
https://doi.org/10.1182/blood.V108.11.1838.1838
Published: 2006
Journal Articles

Hierarchical Organization of Acute Myeloid Leukemia Characterized by Promoter Activity of the Human Telomerase Reverse Transcriptase Gene.

Seiichiro Kobayashi, M.D., Ph.D., Yasushi Soda, M.D., Ph.D., Yuansong Bai, M.D., Ph.D., Hiroyuki Miyoshi, Ph.D., Shigetaka Asano, M.D., Ph.D., Arinobu Tojo, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3381.
https://doi.org/10.1182/blood.V104.11.3381.3381
Published: 2004